The evolving role of glycoprotein (GP) IIb/IIIa receptor blockade during percutaneous coronary intervention of saphenous vein bypass grafts

David J. D'Agate, Snehal Patel, John T. Coppola, John A. Ambrose

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

PCI has improved the treatment of coronary artery disease. However, unlike native coronary arteries, progress in the percutaneous intervention of SVBG has been disappointing, often complicated by distal embolization of atherothrombotic debris and resulting in high periprocedural morbidity. SVBG interventions have an increased incidence of major adverse clinical events compared to native coronary interventions, with approximately 20% of vein graft interventions complicated by myocardial infarction or no-reflow phenomenon. We review the morphological features complicating saphenous vein graft disease, the current literature regarding GP receptor blockade in vein graft interventions and potential future therapies.

Original languageEnglish (US)
Pages (from-to)500-503
Number of pages4
JournalJournal of Invasive Cardiology
Volume16
Issue number9
StatePublished - Sep 1 2004
Externally publishedYes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The evolving role of glycoprotein (GP) IIb/IIIa receptor blockade during percutaneous coronary intervention of saphenous vein bypass grafts'. Together they form a unique fingerprint.

  • Cite this